Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mario Beilmann

1PUBLICATIONS
6CO-AUTHORS
Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 02, 2025
Application of new approach methodologies for nonclinical safety assessment of drug candidates.

Mario Beilmann, Karissa Adkins, Harrie C M Boonen

Pageof 1

Frequent Collaborators

1 joint publications

Harrie C M Boonen

1 joint publications

Philip Hewitt

1 joint publications

Wenyue Hu

1 joint publications

Robert Mader

1 joint publications

Payal Rana

1 joint publications

Thomas Steger-Hartmann

Frequent Collaborators

1 joint publications

Harrie C M Boonen

1 joint publications

Philip Hewitt

1 joint publications

Wenyue Hu

1 joint publications

Robert Mader

Top Related Videos

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on : Oct 20, 2022

1.7K
See more related videos

Top Related Videos

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
08:03

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on : Oct 20, 2022

1.7K
See more related videos